| TTPH Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the TTPH shares outstanding history going back to 3/20/2013:
Also see: TTPH Market Cap History TTPH YTD Return |
As of 5/6/2020 Tetraphase Pharmaceuticals has 7.26 million TTPH shares outstanding. Investors often track the TTPH shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows TTPH share count trends over time, with 30 historical shares outstanding datapoints presented, dating back to 3/20/2013.

| TTPH Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the TTPH shares outstanding history going back to 3/20/2013:
Also see: TTPH Market Cap History TTPH YTD Return |
| TTPH Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
TTPH Historical Shares Outstanding: +36.27% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| TTPH Stock Price Chart |
| About Tetraphase Pharmaceuticals, Inc |
| Tetraphase Pharmaceuticals is a biopharmaceutical company using its proprietary chemistry technology to create, develop and commercialize tetracyclines for serious conditions, including bacterial infections caused by multidrug-resistant (MDR) bacteria. Co.'s product, Xerava (eravacycline), is an intravenous, antibiotic for use as a first-line empiric monotherapy for the treatment of MDR infections, including MDR Gram-negative infections, such as those found in complicated intra-abdominal infections. In addition to Xerava, Co. has also developed other fluorocycline antibiotic compounds, TP-6076 and TP-271, and TP-2846, a tetracycline for the treatment of acute myeloid leukemia. We show 30 historical shares outstanding datapoints in our coverage of TTPH's shares outstanding history. Understanding the changing numbers of TTPH shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like TTPH versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching TTPH by allowing them to research TTPH shares outstanding history as well as any other stock in our coverage universe. |
| TTPH Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| TTPH Share Performance |
| Shares Outstanding Peers |
| Tetraphase Pharmaceuticals (TTPH) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
TVRD Shares Outstanding History TVTX Shares Outstanding History TVTY Shares Outstanding History TWST Shares Outstanding History TXAC Shares Outstanding History TXG Shares Outstanding History TXMD Shares Outstanding History TYME Shares Outstanding History TYRA Shares Outstanding History UBX Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.